Tumor Rejection Effects of Allorestricted Tumor Peptide-Specific CD4(+) T Cells on Human Cervical Cancer Cell Xenograft in Nude Mice
Cell Transplantation (Impact Factor: 3.13). 04/2012; 21(7). DOI: 10.3727/096368912X640510
Generation of tumor specific allo-reactive CD4⁺ T cells is important to circumvent tumor tolerance. Here, we generate allo-restricted peptide-specific CD4⁺ T cells by co-culture of lymphocytes and autologous monocytes bearing allogeneic HLA-DR15 molecule associated with its restricted peptide. Binding of a dimeric HLA-DR15/IgG1-Fc fusion protein (the dimer) to HLA-DR15 negative (HLA-DR15-ve) monocytes made the monocytes coated with the allogeneic epitope. An increased proliferation of CD4⁺ T cells and induction of Th1 cells appeared after co-culturing of HLA-DR15-ve lymphocytes and the autologous monocytes loaded with the dimer. The co-cultural bulks showed an increased frequency of the specific dimer-stained CD4⁺ T cells and the expanded CD4⁺ T cells exhibited an elevated IFN-γ production in response to specific TCR ligand. Tumor rejection effects of the allo-restricted E7-specific CD4⁺ T cells raised by the coculture were observed in nude mice challenged with human cervical cancer cell SiHa expressing both HLA-DR15 and E7 antigens, as the tumor avoidance and lifespan of the mice were improved after adoptive transfer of the CD4⁺ T cells. This study may help to develop strategies to separate graft-versus-leukemia or graft-versus-tumor reaction from graft-versus-host disease, and add to the pool of human high-avidity TCRs specific for tumor or virus antigens.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.